BDF Gestion Invests $2 Million in Neurocrine Biosciences, Inc. $NBIX
MarketBeat
BDF Gestion bought a new position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 11,858 shares of the company's stock, valued at approximately $1,999,
NASDAQ:NBIX